Summarised Study: Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey.
This is a summary of "Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey" by Mike Armour, Justin Sinclair, Geoff Noller, Jane Girling, Maria Larcombe, Mahmoud A. Al-Dabbas, Erika Hollow, Deborah Bush and Neil Johnson, published in Journal of Women's Health. Vol. 30, NO. 10.
Study Methodology
The researchers conducted an online survey of individuals using Cannabis for health-related conditions, specifically those with endometriosis and/or polycystic ovary syndrome (PCOS). They collected data on demographics, how Cannabis was used, symptoms treated, changes in medication usage, and any adverse events.
Reported improved symptoms
Respondents reported that their symptoms were “much better” for:
-
pain (81%)
-
sleep (79%)
-
nausea or vomiting (61%)
TL;DR
-
213 valid responses were analysed.
-
The mean age of respondents was 32 years.
-
79.8% were current Cannabis users.
-
The results showed that Cannabis was commonly used to improve pain relief and sleep, with respondents reporting significant improvements in these symptoms.
-
The most common outcomes that Cannabis was used for were to improve pain relief (95.5%) and sleep (95.5%).
-
81.4% indicated Cannabis had reduced their normal medication usage.
-
59% were able to stop their medications altogether, most commonly painkillers.
-
Opioids (40%) were the most common class of painkillers stopped.
-
Cannabis was reported as an effective intervention for pain and other endometriosis symptoms and could potentially reduce the need for opioids as a painkiller.
Read full study here.
DISCLAIMER: this content has been partially generated by artificial intelligence and should be used for informational purposes only. This content should not be considered as medical advice, always consult your doctor to assess if alternative plant medicine is suitable for you.
Share this article
Summarised Study: Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients.
This is a summary of "Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study' by Alex Capano, Richard Weaver and Elisa Burkman, published in Postgraduate Medicine, Vol. 132, 2020, Issue 1.
